Elser Financial Planning, Inc. has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity holdings as of the close of business on September 30, 2026. The filing lists 132 separate positions held by the firm.
The portfolio is heavily weighted toward exchange-traded funds, with the majority of the listed securities being index funds and ETFs. Major U.S. equity ETFs represented in the filing include the Vanguard S&P 500 ETF Shares (ticker: VOO), the Vanguard Total Stock Market ETF (ticker: VTI), and the iShares Core S&P 500 ETF (ticker: IVV).
Among individual stocks, the largest position disclosed is Eli Lilly & Co., with a holding of 19,259 shares. Other notable individual stock holdings include Abbott Laboratories (22,095 shares), Apple Inc. (26,004 shares), and Johnson & Johnson (8,588 shares). The filing also lists significant positions in Mastercard Incorporated (494 shares) and Visa Inc. Class A (739 shares).
The report indicates that all positions are held as sole voting and dispositive power.
